课题基金 / 基金详情

DNA-DIRECTED EFFECTS OF FdUMP(N)

DNA-DIRECTED EFFECTS OF FdUMP(N)
FdUMP(N) 的 DNA 定向效应
批准号:
7263975
负责人:
William H Gmeiner
金额:
$30.61万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-10 至 2010-07-31
关键词:
Active Biological TransportAffinityAmino Acid SequenceAntineoplastic AgentsApoptoticBindingBiological AssayBiological ModelsCamptothecinCancer cell lineCell Cycle ArrestCell DeathCell LineCell modelCellsCessation of lifeChargeChemicalsClassClinical TrialsCollaborationsColon CarcinomaComplexConfocal MicroscopyDNADNA DamageDNA Double Strand BreakDNA Single Strand BreakDNA-protein crosslinkDU145DataData AnalysesDeoxyglucoseDependenceDevelopmentExclusionExposure toFdUMP(10)Flow CytometryFluorodeoxyuridylateFluorouracilGoalsHeadHumanImmunohistochemistryIsopropanolKineticsLabelLaboratoriesLengthMalignant NeoplasmsMalignant neoplasm of pancreasMalignant neoplasm of prostateMass Spectrum AnalysisMeasuresMediatingMetabolicMetabolismMultienzyme ComplexesNMR SpectroscopyNuclearNucleotidesNude MicePC3 cell linePathway interactionsPeptide Sequence DeterminationPharmaceutical PreparationsPoisonPrecipitationPrimer ExtensionProcessPropertyProstateProstatic EpitheliumProteinsPublishingPulsed-Field Gel ElectrophoresisQualifyingRadioactivityRapid Access to Intervention DevelopmentRefractoryRelative (related person)ReportingResearchResearch PersonnelResearch Project GrantsScintillation CountingSiteSodium AzideStagingStructureStructure-Activity RelationshipTechniquesThymidylate SynthaseTimeTransport ProcessTreatment ProtocolsTrypan BlueType I DNA TopoisomerasesWorkbasecancer cellcapecitabinechemotherapycomputerized data processingcrosslinkcytotoxiccytotoxicitydensityfluoropyrimidinehepatoma cellhuman TOP1 proteinin vivoinhibitor/antagonistinnovationinsightnovelpre-clinicalprogramsprototypereceptor mediated endocytosissizetumor xenograftuptake

项目摘要

项目成果

William H Gmeiner的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): FdUMP[N] compounds constitute a novel class of fluoropyrimidine (FP) chemotherapeutic that may be useful for the treatment of human malignacies that are refractory to current chemotherapy. The goal of this research project is to understand the unique cytotoxic mechanism of FdUMP[N] compounds. Human prostate cancer (PC) cells will be used as a model system to investigate FdUMP[N] cytotoxicity because of the relative sensitivity of PC cells to FdUMP[10], and because of the need for new and more effective drugs to treat late-stage PC. PC results in nearly 30,000 deaths in the U.S. each year. Aim 1 focuses on evaluating the extent that FdUMP[N] multimers enter PC cells via active transport and identifying proteins expressed by PC cells that are involved in receptor-mediated endocytosis. Cellular uptake kinetics will be determined from the time- and concentration-dependence of radioactivity in PC cellular lysates following exposure to 32P-labeled FdUMP[N] compounds. The contribution of active transport to cellular uptake will be evaluated using metabolic inhibitors. Structure/function analyses will be performed to identify structural features of FdUMP[N] compounds that promote intracellular internalization of FdUMP[N] compounds via active transport. Protein(s) involved in the active transport of FdUMP[N] compounds will be identified by UV cross-linking, and sequences for these protein(s) will be determined using mass spectrometry. In Aim 2, the intracellular metabolism of [6-3H]FdUMP[N] compounds to monomeric FP metabolites will be evaluated, and thymidylate synthase inhibition and nucleotide pool imbalances will be quantified. In Aim 3, the misincorporation of FdUTP into DNA and the extent and type of DMA damage, including DNA damage resulting from topoisomerase I cleavage complex formation, will be quantified using alkaline elution, pulsed-field gel electrophoresis, and an in vivo complex of enzyme bioassay. These studies greatly enrich our understanding of the unique cytotoxic mechanism for FdUMP[N] compounds towards PC cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improved Treatment of Colorectal Cancer with CF10
  • 批准号:
    10698394
  • 项目类别:
  • 资助金额:
    $96.45万
  • 财政年份:
    2023
  • 负责人:
    William H Gmeiner
  • 依托单位:
Nanodelivery of FP polymers to improve treatment of metastatic colorectal cancer
Improved Treatment of Colorectal Cancer with CF10 Diversity Supplement
  • 批准号:
    10543218
  • 项目类别:
  • 资助金额:
    $10.45万
  • 财政年份:
    2022
  • 负责人:
    William H Gmeiner
  • 依托单位:
Improved Treatment of Colorectal Cancer with CF10
  • 批准号:
    10254547
  • 项目类别:
  • 资助金额:
    $39.64万
  • 财政年份:
    2021
  • 负责人:
    William H Gmeiner
  • 依托单位:
海外基金